BridgeMD
New treatment option for Diabetes
Official title Continuous Glucose Monitors (CGMs) for All: Studying the Impact of Expanding CGM Access
ClinicalTrials.gov ID: NCT06658067
What this study is testing
- What it's testing
- This non-blinded, non-randomized pre-post study will examine the impact of providing CGM sensors free of charge to adult patients of Fair Haven Community Health Care with poorly controlled type 2 diabetes on glycemic control and quality of life.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Provision of signed and dated informed consent form
- Stated willingness to comply with all study procedures and availability for the duration of the study
- Diagnosed with type 2 diabetes mellitus
- A1c greater than or equal to 8.0 within two weeks of the time of enrollment
- On insulin for at least one year +/- other antihyperglycemics
You likely can't join if
- Insulin naïve
- Diabetic ketoacidosis (DKA) in previous 6 months
- End-Stage Renal Disease (ESRD)
- Contraindications to CGM use
- Active insurance plan that would provide enough of a subsidy for participant to feasibly purchase CGM sensors
- Pregnancy
See the full eligibility criteria
- Provision of signed and dated informed consent form
- Stated willingness to comply with all study procedures and availability for the duration of the study
- Diagnosed with type 2 diabetes mellitus
- A1c greater than or equal to 8.0 within two weeks of the time of enrollment
- On insulin for at least one year +/- other antihyperglycemics
- Ability and willingness to wear CGM for 14-day periods throughout the trial period
- Ability and willingness to comply with provider-directed adjustments to medication regimen
- Inability to afford CGM sensors A note on Vulnerable Populations: Many of FHCHC's patients are economically disadvantaged and of minority backgrounds; the clinic's patient base may be considered to constitute a...
- Insulin naïve
- Diabetic ketoacidosis (DKA) in previous 6 months
- End-Stage Renal Disease (ESRD)
- Contraindications to CGM use
- Active insurance plan that would provide enough of a subsidy for participant to feasibly purchase CGM sensors
- Pregnancy
The study team makes the final eligibility decision.
Where it's taking place
- New Haven, Connecticut, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include New Haven, Connecticut, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.